Injectafer (American Regent, Inc.)


Welcome to the PulseAid listing for the Injectafer drug offered from American Regent, Inc.. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: American Regent, Inc.
NON-PROPRIETARY NAME: Ferric Carboxymaltose Injection
SUBSTANCE NAME: FERRIC CARBOXYMALTOSE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-08-12
END MARKETING DATE: 0000-00-00


Injectafer HUMAN PRESCRIPTION DRUG Details:

Item DescriptionInjectafer from American Regent, Inc.
LABELER NAME: American Regent, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 2013-08-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0517-0650_33fd0936-5b19-4cc5-bb74-a2789a8cfb88
PRODUCT NDC: 0517-0650
APPLICATION NUMBER: NDA203565

Other FERRIC CARBOXYMALTOSE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Injectafer